Hydrochloric Acid → HCID 21073794, compound
Reaction equation
[O:1]1[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][C:9]=2[N:11]2[CH2:16][CH2:15][N:14]([CH2:17][CH2:18][CH2:19][CH2:20][O:21][C:22]3[CH:23]=[CH:24][C:25]4[CH:30]=[N:29][C:28](=[O:31])[NH:27][C:26]=4[N:32]=3)[CH2:13][CH2:12]2)[CH2:4][CH2:3][CH2:2]1.[BH4-].[Na+].Cl.CCOCC>C1COCC1.CO>[O:1]1[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][C:9]=2[N:11]2[CH2:12][CH2:13][N:14]([CH2:17][CH2:18][CH2:19][CH2:20][O:21][C:22]3[CH:23]=[CH:24][C:25]4[CH2:30][NH:29][C:28](=[O:31])[NH:27][C:26]=4[N:32]=3)[CH2:15][CH2:16]2)[CH2:4][CH2:3][CH2:2]1Participants
Procedure
To a solution of 7-[4-(4-chroman-8-yl-piperazin-1-yl)-butoxy]-1H-pyrido[2,3-d]pyrimidin-2-one (320 mg) in THF (6 mL) and MeOH (2 mL) was added NaBH4 (54 mg) in portions. After the addition was over, the mixture was kept stirring overnight. The reaction was quenched with H2O. The mixture was extracted with CH2Cl2 (3×50 mL). The combined organic phases were dried over Na2SO4 and concentrated. The residue was purified by chromatography on silica gel to give a semi-solid which was converted to its HCl salt by treating with 1 equivalent of 1 N HCl in a mixed solvent of THF and Et2O to give the title compound (147 mg) as a white solid. 1H NMR (400 MHz, DMSO-d6): δ 9.20 (s, 1H), 7.40 (d, 1H), 6.98 (s, 1H), 7.70 (m, 3H), 6.25 (d, 1H), 4.30–4.06 (m, 6H), 3.60–3.30 (m, 4H), 3.15 (m, 4H), 3.00–2.70 (, 4H), 2.00–1.60 (m, 6H).
Workup
- additionAfter the addition
- customThe reaction was quenched with H2O
- extractionThe mixture was extracted with CH2Cl2 (3×50 mL)
- dry with materialThe combined organic phases were dried over Na2SO4
- concentrationconcentrated
- customThe residue was purified by chromatography on silica gel
- customto give a semi-solid which
Sources & evidence
- ORD record
- ord-304444adade74457a572ba1024204ae5
- Source dataset
- uspto-grants-2007_01
- Patent number
- US07160888B2
Reaction notes
Loading…